MiMedx Group, Inc.MDXGNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank64
3Y CAGR-7.1%
5Y CAGR+34.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-7.1%/yr
Annual compound
5Y CAGR
+34.0%/yr
Recent deceleration
Percentile
P64
Within normal range
vs 5Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 22.33% |
| 2024 | -2.56% |
| 2023 | -0.28% |
| 2022 | 27.88% |
| 2021 | -15.22% |
| 2020 | 5.16% |
| 2019 | -29.34% |
| 2018 | -11.93% |
| 2017 | 24.82% |
| 2016 | 70.46% |